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Background
Pseudogenes occupy a significant portion of vertebrate
genomes, and are especially prevalent in the mammalian
genomes [1-6]. It is estimated that the human genome may
contain approximately 20,000 pseudogenes and pseudogene
fragments [1,4]. These are copies of functional genes that
have lost their potential as DNA templates for functional
products (for example, proteins). Usually, they have accu-
mulated various detrimental sequence mutations (for
example, nonsense mutation) during evolution. Based on the
processes of their formations, pseudogenes are often
separated into: processed pseudogenes, which have been
retrotransposed back into a genome from mRNA inter-
mediates; and non-processed pseudogenes [2,5,6].
Pseudogenes have traditionally been recognized as an
important resource for exploring dynamics and evolutionary
history of genes and genomes. The common wisdom is that
pseudogenes are non-functional and evolve neutrally.
Therefore, they are often used for calibrating the parameters
in various models of molecular evolution. However, some
pseudogenes are transcribed and a few of them have been
indicated to be involved in biological processes [5,7-9].
While the functional roles of pseudogenes are yet to be
elucidated with more studies, the prevalence of pseudogenes
in mammalian genomes has been problematic for gene
annotation [10,11]. Because of high sequence similarity with
functional genes, pseudogenes can sometimes be mistakenly
annotated as genes, especially in an automated annotation
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Abstract
Background: Pseudogenes are inheritable genetic elements showing sequence similarity to
functional genes but with deleterious mutations. We describe a computational pipeline for
identifying them, which in contrast to previous work explicitly uses intron-exon structure in
parent genes to classify pseudogenes. We require alignments between duplicated pseudogenes
and their parents to span intron-exon junctions, and this can be used to distinguish between true
duplicated and processed pseudogenes (with insertions).
Results: Applying our approach to the ENCODE regions, we identify about 160 pseudogenes,
10% of which have clear ‘intron-exon’ structure and are thus likely generated from recent
duplications.
Conclusions:  Detailed examination of our results and comparison of our annotation with the
GENCODE reference annotation demonstrate that our computation pipeline provides a good
balance between identifying all pseudogenes and delineating the precise structure of duplicated genes.
Open Accesspipeline. The task of distinguishing real genes from duplica-
ted pseudogenes (a subtype of non-processed) is even more
challenging. Therefore, the correct identification of pseudo-
genes is not only essential for subsequent pseudogene
studies per se but also important for the overall accuracy of
gene annotation [11].
Several computational algorithms have been described
previously for annotating human pseudogenes [1,4,9,10,12-
16]. All of them identify pseudogenes based on their two key
sequence properties: similarity to genes and non-function-
ality. In practice, the former is often characterized by the
sequence similarity between a pseudogene and its closest
functioning gene relative (referred to as the ‘parent gene’) in
the present-day genome. The latter is somewhat more elusive
but is most commonly manifested by the occurrence of
disablements (that is, premature stop codons, frameshifts and
indels) in the ‘putative coding region’ of a pseudogene. Using
such features as a pseudogene signature, Zhang et al. [1]
identified approximately 8,000 processed pseudogenes in the
human genome. The total number of human pseudogenes has
been estimated to be between 10,000 and 20,000 according to
this study and analyses from other groups [1,4,12,13].
Here we describe our pseudogene annotation for the
ENCODE regions in the human genome. Our current
computational pipeline contains various modifications and
improvements from previous methods [1,9,16], with a new
emphasis on delineating the precise structures of pseudo-
genes arising from recent gene duplication. Unlike their
processed counterparts, duplicated pseudogenes arise from
gene duplication and usually have intron-exon like struc-
tures inherited from their gene ancestors. This structure is
also present in a unitary pseudogene, which has no
functional relative in the same genome. The constituents of
these structures may be called ‘pseudo-introns’ and ‘pseudo-
exons’, terms that will be used in this paper. Previously, such
‘introns’ were inferred by aligning a pseudogene’s nucleotide
sequence to its parent gene’s protein [1,4,13,14,16]. They
were then used to distinguish duplicated from processed
pseudogenes. As a result, processed pseudogenes with inser-
tions (for example, transposons) could be incorrectly
classified as duplicated unless extra care had been taken
[16]. Our current method examines the preservation of a
parent gene’s intron-exon structure in a pseudogene and
uses it as direct evidence for identifying duplicated pseudo-
genes. Applying this approach to the ENCODE regions found
164 pseudogenes (note that this number refers to the status
in August 2005), which overlap very well with a reference set
of manually curated pseudogenes from the GENCODE
research group [17]. In addition, we found that 16 duplicated
pseudogenes have their ‘introns’ and ‘exons’ arranged in the
same patterns as those of their parent genes. These results
demonstrate that our pipeline can identify pseudogenes
correctly, and, as importantly, can delineate the precise
structures of duplicated pseudogenes.
Results
Overview of our pipeline and number of pseudogenes
in ENCODE regions
Gene prediction usually starts with the building of gene
models from a specific training set of genes [11]. These
models are subsequently applied to predict genes in un-
annotated genomic sequences. Many algorithms are presen-
ted in accompanying papers in this special ENCODE Genome
Annotation Assessment Project (EGASP) issue [18]. The
special characteristics of pseudogenes, on the other hand,
have led researchers to adopt rather different strategies for
their prediction. A homology-based approach like ours scans
a genome for DNA sequences similar to a set of query genes.
The resulting gene-like sequences are then scrutinized and
those possessing pseudogene features are extracted. It is
obvious that such a method requires a good set of known
genes that is as complete and accurate as possible. After
evaluating several data sources (data not shown), we decided
to use the annotation from the ENSEMBL [19]. To be
precise, we used version 29.35e (released in March 2005),
which contained 24,194 genes (including 1,978 pseudo-
genes) and 28,479 proteins (composed of 292,306 non-
redundant exons).
One criterion commonly used for separating processed and
non-processed pseudogenes is based on the occurrence of
pseudo-intron(s). Processed pseudogenes should have no
pseudo-introns as they are the consequence of retrotrans-
position, but the non-processed ones typically retain introns
or at least parts of them. In order to explore such a differ-
ence, we implemented a computational pipeline composed
of two routines, with one (routine P) focusing on processed
pseudogenes and the other (routine D) on duplicated ones
(Figure 1). The major difference of these two routines lies in:
the homology search step, where D uses individual exons
while P uses full length proteins as queries; the step of
assembling BLAST [20] hits into putative pseudogenes,
where only D explicitly uses the intron-exon information of
query genes (see Materials and methods for details). Putative
pseudogenes from the P and D routines were combined and
further inspected before they were finally classified. In our
work, we specifically separated non-processed pseudogenes
further into duplicated pseudogenes and fragments. The
former have recognizable ‘intron-exon’ arrangements nearly
identical to that of their parent genes whereas the latter do not.
In the end, the above pipeline identified a total of 211 pseudo-
genes (provided to EGASP/2005 in May 2005) in the
ENCODE regions. Of these, 27 turned out to be LINE/SINE
fragments after cross-reference with an updated version of
RepeatMasker library. Excluding them, we identified 184
pseudogenes (Table 1), of which 93 were classified as
processed, 19 as duplicated and 72 as pseudogene fragments.
We also found one instance of a partially processed
pseudogene; it is located at ENm011:80704-81919. The
parent gene β-actin contains five exons. The processed
S13.2 Genome Biology 2006, Volume 7, Supplement 1, Article S13 Zheng and Gerstein http://genomebiology.com/2006/7/S1/S13
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Figure 1
A flow chart of our computational pipeline for identifying pseudogenes. It contains two parallel procedures, one on the left (routine P) is mainly for
processed pseudogenes and the other on the right (routine D) is for duplicated pseudogenes. The steps common to both are shown at the top and in
the bottom. Both procedures searched the ENCODE regions for DNA sequences similar to human genes as annotated by the ENSEMBL. The two
routines differ in how to perform the search and how to process the search results. The key differences are highlighted with blue in P and orange in D.
At the end, an alignment between a known gene and a pseudogene candidate was constructed either by TFASTY or GeneWise. Information in this
alignment and the computational path taken by a pseudogene were used together to separate pseudogenes into three classes: duplicated, processed and
fragment.
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while the remaining three introns have been spliced out.
The 44 ENCODE regions were picked with a variety of gene
densities and conservation [21]. As shown in Figure 2, the
number of pseudogenes varies in different regions. Many
have only one or two pseudogenes, but two (ENm007 and
ENm009) contain more than 20. Both of these two regions
are also gene dense [17]. ENm009 contains the well
characterized  β-globin locus and is known to have many
olfactory receptor (OR) pseudogenes [22]. In fact, 24 of our
29 pseudogenes in ENm009 were identified with olfactory
receptor genes as their parent genes. Since the coding region
of an OR gene is intronless, all but one OR pseudogene were
put into the group of pseudogene fragments in our pipeline.
Overall, the number of pseudogenes appears to correlate
well with the number of genes in individual regions
(r2 = 0.65) (Figure 2).
Duplicated pseudogenes
Duplicated pseudogenes are an important evolutionary
residue of a genome’s past activity. It is generally thought
that gene duplication is one of the main driving forces for
creating genes with novel functions [23] . Therefore, the
accurate identification of duplicated pseudogenes is valuable
both for understanding the process of gene duplication and
for studying the subsequent evolutionary fate of duplicated
genes, which can either lead to gene death (that is, becoming
a pseudogene or deleting a gene) or gene birth (that is,
S13.4 Genome Biology 2006, Volume 7, Supplement 1, Article S13 Zheng and Gerstein http://genomebiology.com/2006/7/S1/S13
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Table 1
Separation of 184 pseudogenes in ENCODE regions identified in
this study
Final pseudogene  Detected only  Detected by  Detected only 
type* by routine P both routines by routine D
Processed 60 30 3
Non-processed
Duplicated 3 13† 3
Fragment 60 1 11
*The types are the final classification after information from routines P
and D was combined. They could be different from a pseudogene’s initial
type labeled in either routine P or D. †In routine P, two were annotated
as processed and two as fragments and another four were identified
partially.
Figure 2
Distribution of 184 pseudogenes in ENCODE regions. Pseudogenes were first grouped into processed and non-processed (duplicated and fragments).
Their numbers in the 44 ENCODE regions are plotted. The inserted panel shows that the number of pseudogenes is approximately correlated to that of
genes within individual regions.
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sarising of a gene with new function). Only 19 of the 91 non-
processed pseudogenes retain clear evidence of duplication,
as supported by the preservation of intron-exon structures
matching to their parent genes. The longest one contains 10
pseudo-exons spanning about 19,000 nucleotides. However,
most of them (16) have lost at least one exon from their
ancestors based on comparisons with their modern gene
relatives. Notably, five of our duplicated pseudogenes are on
the same chromosome as their parent genes, suggesting that
they may have arisen from local gene duplication.
The majority of non-processed pseudogenes did not contain
a pseudo-intron and, therefore, were classified as fragments.
With the exception of OR pseudogenes, which originate from
single-exon genes, most of them only match a short
fragment of their parent proteins. They may represent single-
exon duplication of their parent genes or have entirely lost
their original intron-exon signatures. In this sense, it is
appropriate to say that the duplicated pseudogenes identi-
fied by us arise from recent events of gene duplication.
Brief comparison of data from routines P and D
We merged pseudogenes from our two computational
routines. We have examined how pseudogenes were identified
and labeled by these two routines. As shown in Table 1,
nearly all processed pseudogenes were detected (and labeled
correctly; data not shown) in routine P. Routine D is
intended for duplicated pseudogenes, but we allow it to pick
up processed ones as well (see Materials and methods for
details). In fact, it recognized one-third of our final 93
processed pseudogenes with an additional three not detected
in routine P. These three were quite short and shared rather
weak sequence similarity with their parent genes, so they
were filtered out in routine P.
As mentioned above, approximately 80% of non-processed
pseudogenes did not have a pseudo-intron and in many
cases could be reliably aligned to only a fraction (<70%) of
their parent genes. These were classified as pseudogene
fragments [1,16]. Since they did not contain detectable
pseudo-introns, they look like ‘processed pseudogenes’ and
were mainly identified from routine P as expected. Most (25)
OR pseudogenes were in this class; they actually result from
gene duplication but were classified as pseudogene
fragments in our computational scheme.
Most final duplicated pseudogenes were discovered by both
D and P routines. It might appear that this defeats the whole
purpose of routine D. However, detecting the presence of a
pseudogene is one thing but recovering its full structure with
accurate pseudo-intron-exon boundaries is another. The
goal of routine D is really the latter. For six cases, only part
of the pseudogene was identified in routine P while the
entire structure with pseudo-exons and pseudo-introns was
correctly annotated in routine D. Furthermore, two of these
six were labeled as processed in routine P. These inaccuracies
would not have been corrected without information from
routine D. On the other hand, to our surprise, three dupli-
cated pseudogenes were missed in routine D. Further
manual inspection showed that one in ENm001 (1092641-
1094417) was more likely to be a processed pseudogene
disrupted by a 1.2 kb DNA insertion; the other two (ENm006:
796815-805109; ENm008: 4095-8064) were almost
identical (>95% sequence identity) to their parent genes. In
routine D, we did not analyze genomic sequences with the
latter feature.
In conclusion, the above results indicate that by combining
two routines our computation pipeline provides a good
balance between detecting all pseudogenes and identifying
the exact structure of duplicated pseudogenes.
Comparison with GENCODE/HAVANA annotation
The GENCODE group and the HAVANA team have
produced a high quality manual annotation for ENCODE
regions, including 521 genes and 167 pseudogenes [17].
These served as the gold standard for evaluating other
prediction methods in the EGASP/2005 workshop [18].
Table 2 summarizes the comparison between our pseudo-
genes and HAVANA annotation; 136 of our 184 pseudogenes
overlapped with 135 of their pseudogenes. One-quarter of
pseudogenes was unique to each method. This is a very
promising result since pseudogenes annotated by different
methods often did not agree very well [9,14].
In addition, 95 and 20 of our pseudogenes intersected with
introns and exons from GENCODE, respectively. The over-
lapping between our pseudogenes and exons raises an
important issue. Our method uses annotated genes for two
purposes: as queries to search for similar genomic
sequences; and as filters to eliminate exon sequences (that
is, remove known genes). In our work, the gene annotation
was obtained from the ENSEMBL, which contained 576
predicted genes in the ENCODE regions. Any discrepancy
between ENSEMBL and the HAVANA/GENCODE anno-
tation would be carried over to our annotation. For example,
six GENCODE pseudogenes overlapped with ENSEMBL
exons and thus could not be found by us. Conversely, some
pseudogenes in our list could be components of genes
missed by the ENSEMBL. Of the 20 overlapping with
GENCODE exons, 11 were classified as pseudogene
fragments, suggesting that they probably are real exons
missed in our gene collection.
In order to illustrate the difficulty of gene/pseudogene
annotation, we present two cases of discrepancy between our
pseudogene annotation and GENCODE’s gene prediction.
First, in ENr122, we predicted a duplicated pseudogene at
359245-366200. There is a frame shift mutation in this
pseudogene as shown in its alignment with an ENSEMBL
protein ENSP00000331368 (Figure 3a). The parent gene
(Serpin B8 or CAP-2) is in very close vicinity at
http://genomebiology.com/2006/7/S1/S13 Genome Biology 2006, Volume 7, Supplement 1, Article S13 Zheng and Gerstein  S13.5
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hENr122:375942-395286 (chr18: 59788243-59807587). This
pseudogene contains three pseudo-exons corresponding to
the first three exons of the parent gene, which has seven
exons. It overlaps a GENCODE gene whose transcript (ID:
‘AC009802.2-001’) contains our three pseudo-exons and
one extra untranslated exon at the 5’ end. The disablement is
in the first pseudo-exon (Figure 3a). However, if this
disablement is skipped and an internal ATG is used as an
alternative translation start site, a truncated protein can be
produced. Without further experiments, the contradictory
annotations for this region can not be resolved convincingly.
In the second case, we predicted a pseudogene at
ENm005:200473-211501. Again, a frameshift mutation was
found in the fourth pseudo-exon as shown in its alignment
with an ENSEMBL protein ENSP00000283507 (Figure 3b).
The parent gene (TCP-10) is in a different chromosome at
chr6: 167554536-167579329. The pseudogene retains the
intact structure of its parent gene with six exons and five
introns. The first four pseudo-exons were included in a five-
exon GENCODE transcript (ID: ‘AP000274.7-001’). There is
a full length cDNA (H-Inv: HIT000014684) matching this
transcript, suggesting that this is likely a gene instead of
pseudogene. However, transcription alone cannot be used as
exclusive evidence to disapprove a pseudogene annotation
because some pseudogenes are transcribed [9].
Comparison with known pseudogenes
We compared our annotation to a few available known
pseudogenes in the ENCODE regions. We began with four
duplicated pseudogenes. Previously, a transcribed β-globin
pseudogene (HBBP1) [24] in ENm009 was discovered with a
substitution mutation in the start codon, a nonsense muta-
tion in codon 15 and frameshift mutations in the second and
third exons. It was detected by us and GENCODE
annotators, but both predicted a shorter version (Table 3).
We did not observe sequence similarity for the 1 kb sequence
at the 3’ end. Two α-globin and one ζ-globin pseudogene
have also been described in ENm008 [25] (Table 3). One of
the  α-globin pseudogenes was present in the GENCODE
annotation and ours as well. The other was missed by both
groups because of its low sequence similarity to the parent
gene,  α-globin. (Note, we did find part of it during a
homology search, but we did not pursue it because of its
short sequence and no disablement.) The ζ-globin
pseudogene is nearly identical to the ζ-globin gene except a
single nonsense mutation in codon 7 [25]. It was identified
in routine P but this stop codon was not displayed by
alignment tools (see Discussion). Since this disablement was
not visible and the remaining material was very similar
(>95%) to the gene, we (perhaps over-cautiously) treated the
sequence as a gene and did not report it.
Finally, previous studies have annotated many OR
pseudogenes in ENm009 [22]. Since these are single exon
pseudogenes, they are relatively easy to identify with
computational pipelines. We found the majority of them and
two examples are listed in Table 3.
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Figure 3
Two pseudogenes inconsistent with GENCODE gene annotation. (a) A
pseudogene in ENr122: 359245-366200 (+) and its alignment with an
ENSEMBL protein ENSP00000331368 (Serpin B8). This pseudogene
overlaps a GENCODE gene whose transcript (ID: ‘AC009802.2-001’)
contained the three pseudo-exons and one additional 5’ exon. (b) A
pseudogene at ENm005:200473-211501 (-) and its alignment with an
ENSEMBL protein ENSP00000283507 (TCP-10 homolog). The first four
pseudo-exons were included in a five-exon GENCODE transcript (ID:
‘AP000274.7-001’). The frameshift mutations (‘!’ in the alignment) in both
pseudogenes are highlighted.
 
ENSP00000331368    1 MDDLCEANGTFAISLFKILGEEDNSRNVFFSPMSISSALAMVFMGAKGS  
                     MD L EANGTFA++L+K LGE  NS N+FF PMSISSALAMVFMGAKG+  
ENr122_359268_3   11 MDALSEANGTFALNLLKKLGE-NNSNNLFF!PMSISSALAMVFMGAKGN  
 
ENSP00000331368   50 TAAQMSQ                       ALCLYK----DGDIHRGFQ  
                     TAAQMSQ         Intron 1      ALC  K    DGDIHRGFQ  
ENr122_359268_3  154 TAAQMSQ<0-----[175  : 1054]-0>ALCFSKIGGEDGDIHRGFQ  
 
ENSP00000331368   72 SLLSEVNRTGTQYLLRTANRLFGEKTCDFLP                    
                     SLL  +NRT T+Y+LRTAN LFGEK+ DFL      Intron 2       
ENr122_359268_3 1112 SLLVAINRTDTEYVLRTANGLFGEKSYDFLT<0-[1205 :6804]-0>         
 
ENSP00000331368  103 DFKEYCQKFYQAELEELSFAEDTEECRKHINDWVAEKTEGK 
                      F + C KFYQA +++L F  DTE+    +N WVA+KT+G+ 
ENr122_359268_3      GFTDSCGKFYQATIKQLDFVNDTEKSTTRVNSWVADKTKGE 
 
 
 
 
ENSP00000283507    1 MLEGQLEAREPKEGTHPEDPCPGAGAAMEKTPAAAEVPREDSNAGEMP   
                     ML GQLEAR+PKEGTHPEDPCPGAGA MEKT  AAEV  ED N GEMP   
ENm005_200473_ -9777 MLAGQLEARDPKEGTHPEDPCPGAGAVMEKTAVAAEVLTEDCNTGEMP   
 
ENSP00000283507   49                        SLQQQITSLHQELGRQQSLWADIHRK  
                              Intron 1       LQQQI  LHQELGRQ+SLWAD+H K  
ENm005_200473_ -9633 <0-----[9633 : 7889]-0>PLQQQIIRLHQELGRQKSLWADVHGK  
 
ENSP00000283507   75 LQSHMDALRKQNRELREELRGLQRQQWEAGKKPAASPHAGRESHTL     
                     L+SH+DALR+QN ELRE+LR LQ Q+W+A KK AASPHAG+ESHTL     
ENm005_200473_ -7810 LRSHIDALREQNMELREKLRALQLQRWKARKKSAASPHAGQESHTL     
 
ENSP00000283507  121                        ALEPAFGKISPLSADEETTPKYAGRK  
                              Intron 2      ALEPAFGKISPLSADEET PKYAG K  
ENm005_200473_ -7672 <0-----[7672 : 4305]-0>ALEPAFGKISPLSADEETIPKYAGHK  
 
ENSP00000283507  147 SQSATLLGQRWSSNHLAPPK                       PMSLKT  
                     +QSATLLGQR SSN+ APPK         Intron 3      PMSLK   
ENm005_200473_ -4226 NQSATLLGQRSSSNNSAPPK<0-----[4166 : 2397]-0>PMSLKI  
 
ENSP00000283507  173 ERINSGKTPPQEDREKSPPGRRQDRSPAPTGRPTPGAERREVSEDGK    
                     ERI+S KTPPQE+R+K+   RRQDR   PTGRPTP AERR VSEDGK    
ENm005_200473_2-2378 ERISSWKTPPQENRDKNLSRRRQDRRATPTGRPTPCAERR!VSEDGK    
 
ENSP00000283507  220                        IMHPSSRSLQNSGGRKSPVQASQAAT  
                              Intron 4       MHPSSRSLQN  GRKSPVQASQAA   
ENm005_200473_2-2236 <0-----[2236 : 1797]-0>AMHPSSRSLQNLSGRKSPVQASQAAM  
 
ENSP00000283507  246 LQEQTAAAGVA                          RSSSVLGSSEGG  
                     LQEQ AAAG A          Intron 5         SSSVL SSEGG  
ENm005_200473_ -1718 LQEQMAAAGGA <1-----[1684 :  150]-1>  GSSSVLESSEGG  
 
ENSP00000283507  270 FLSRVQAEEFASSSPDSAERQ                              
                     FLS VQ +EF +SSP+ AE Q                              
ENm005_200473_ -2111  FLSHVQPDEFTASSPNIAELQ      
(a)
(b)
Table 2
Overlapping of our 184 pseudogenes with GENCODE
annotations
GENCODE annotation
Annotation in  Non- Not
this study Processed processed annotated Exons
Processed 70 7 13 3
Non-Processed 15 44 17 17
Not Annotated 15 18 - -Discussion
Genes, especially protein coding genes, have been and will
remain the major focus of research on the genome. The
launch of the ENCODE project, however, aims to identify all
structural and functional elements in the human genome
[21]. Pseudogenes are a major component of our genome
and a few of them have been suggested to have functions.
Nevertheless, pseudogene annotation is often considered as
a side-project or by-product of gene annotation. However,
most pseudogenes have traceable origins and sequence
features distinct from genes, suggesting that computational
strategies specific to pseudogene prediction are necessary.
In this paper, we describe our general algorithm for
annotating pseudogenes. For the EGASP held in May 2005,
we identified 184 pseudogenes, of which 136 overlap with
the reference set of pseudogenes manually curated by the
GENCODE team. About a quarter of the pseudogenes are
unique to our own method. Although pseudogene prediction
was not part of the official competition in EGASP [18], it was
discussed extensively during the workshop. In addition,
several research groups have subsequently been working
together to obtain an accurate pseudogene annotation in the
44 ENCODE regions, and to improve methods that can be
applied to the entire genome.
Limitation of our methods and future improvement
Gene annotation is in flux, so is pseudogene identification
Eighteen pseudogenes unique to our method were found to
intersect with exons predicted by GENCODE (Table 2).
Although a few of these pseudogenes may be bone fide
pseudogenes, many of them are likely components of
functional genes. A homology-based approach like ours
needs gene annotation to compile a list of known genes (and
proteins) as queries and as filters for eliminating genic
sequences. Therefore, our result is limited by the source of
gene annotation. Since annotation of the human genome is
an ongoing dynamic process, our result will also be in flux.
In this study, we used the ENSEMBL annotation [19]
because of its good coverage of the human genome. It is also
deeper than the RefSeq collection [26] but more specific
than annotation derived purely from computation prediction
using software like GenScan [11,27]. Having said that, we
note that the ENSEMBL gene collection in itself includes
some pseudogenes, due to the complexity of gene annotation
as discussed above. For example, the human genome has
three GAPDH and 80 ribosomal protein genes, but harbors
approximately 80 GAPDH pseudogenes and approximately
1,700 ribosomal protein pseudogenes [1,13]. Some of these
pseudogenes were incorrectly annotated as genes by
ENSEMBL.
Another issue in relation to the quality of the data source is
the correct identification of repetitive sequences. If these
sequences are not masked, they could be easily annotated as
pseudogenes simply because they have the features of
pseudogenes (and they are pseudogenes in some sense). As a
matter of fact, we mistook 27 LINE/SINE sequences as
pseudogenes. It is fair to say we would have not annotated
the above 20 gene components and 27 repeats as pseudo-
genes if the relevant information was available to us in the
beginning.
Need a better way to align a pseudogene to its parent protein
sequence
The assessment of a genomic sequence as a pseudogene
depends on the correct identification of its parent gene and
the alignment between them. Currently, we assume that the
most similar gene in the present-day genome represents the
parent. This assumption may introduce unexpected artifacts
into the alignment between a gene and its pseudogene
relative, as both are descendents of an ancestral functional
gene. Another practical issue is how to construct a ‘correct’
alignment. Stop codons and frameshifts are accommodated
by programs like GeneWise [28] and TFASTY [29], but such
disablements can break an alignment and leave it
incomplete. Fundamentally, these programs are developed
for genes so disablements are strongly disfavored in
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Table 3 
Examples of known pseudogenes in ENCODE regions
Name Region Pseudogene location Our annotation GENCODE annotation
β-globin ENm009 488570-490726 (-) 489920-490351 (-) 488931-490348 (-)
α-globin ENm008 156150-156704 (+) NA NA
α-globin ENm008 158635-159503 (+) 158920-159084 (+) 158678-159333 (+)
ζ-globin ENm008 152711-155400 (+) NA 153121-155155 (+)
OR51H2P ENm009 123369-124314 (+) 123353-124305 (+) 123368-124273 (+)
OR51B8P ENm009 577399-578156 (-) 577369-578174 (-) 577403-578171 (-)
NA, not annotated.constructing alignments. This is the reason for our failure to
identify the ζ-globin pseudogene in ENm008. This
pseudogene contains a nonsense mutation in codon 7, but the
rest of the sequence is identical to ζ-globin gene. Both
GeneWise and TFASTY constructed an alignment starting
from codon 8 that totally ignored the first seven codons. As a
result, we overlooked this pseudogene. This case clearly
indicates that a better tool is needed to align a pseudogene to
its parent gene. An algorithm specifically designed for aligning
pseudogenes [30] appears promising and a new program,
GeneMapper [31], may be useful for addressing this problem.
Strength and limitation of our computational pipeline
Processed pseudogenes are derived from processed mRNA.
They are usually not disrupted by large indels and thus
easier to be identified than duplicated pseudogenes. Our
pipeline, especially through routine P, is very good at
identifying these pseudogenes. In routine P, the presence of
pseudo-intron is inferred if an insertion (relative to its
parent protein in the alignment) larger than a threshold (for
example, 60 bp) is found in a pseudogene. As shown in
Table 2 and discussed above, this parameter is sufficient for
detecting most duplicated pseudogenes even though it may
not lead to the identification of the full length pseudogenes.
However, it will misclassify disrupted processed pseudo-
genes as duplicated ones. To overcome this limitation, we
developed routine D, which explicitly uses the intron-exon
structure of a parent gene to classify duplicated pseudo-
genes. This idea appears very reasonable but it assumes that
the intron-exon structure of a gene is at least partially
preserved in its pseudogene relatives. Further investigation
will be required to validate this assumption. Nevertheless,
the combination of routines P and D provides a good balance
between discovering all pseudogenes and identifying the
exact structure of duplicated pseudogenes.
Conclusions
Using a homology-based approach, we have identified 184
pseudogenes in the ENCODE regions. The majority of them
(74%) overlap with high quality pseudogenes annotated by
the GENCODE group and the HAVANA team, an indication
that our method worked successfully. Excluding the 20
pseudogenes overlapping with GENCODE exons, we would
obtain a set of 164 pseudogenes, of which 91 are processed,
16 are duplicated, and the rest are tentatively classified as
fragments. The list of our final 164 pseudogenes and the two
ambiguous cases described above (Figure 3) can be found at
[32]. This work also provides some insights for improving
our approach in the future. At the current stage, there are
not enough experimentally reported pseudogenes to establish
a gold standard dataset for evaluating different prediction
methods. However, several groups have worked together to
reach a consensus and reliable list of pseudogenes for the
ENCODE regions. Relevant information of that project is
available at [33].
Materials and methods
Genomic sequence and annotated genes
The human genome sequence (build 35) was downloaded
from the ENSEMBL [19] and sequences of the 44 ENCODE
regions were extracted to serve as targets of our pseudogene
annotation. Gene annotation was also obtained from the
ENSEMBL. It included a set of known genes (as defined by
ENSEMBL), with their intron, exon positions and their
corresponding protein sequences.
Our computational pipeline contains two routines, with each
focusing on a special type of pseudogene (Figure 1). In both
routines, repetitive and exonic sequences in the ENCODE
regions were masked.
Routine P focuses on processed pseudogenes
Processed pseudogenes are generated by retrotransposition,
the process of reverse transcription of a processed mRNA
into DNA and its subsequent insertion into a genome. As a
consequence, these pseudogenes usually do not contain
pseudo-introns. Although some of them may contain indels,
they generally can be reliably aligned to their parent proteins,
and the alignments often expand the full parent sequences.
In recognition of this, routine P (for ‘processed’) uses human
protein sequences in their full lengths as queries to search
for pseudogenes. The steps (Figure 1) involved in this routine
have been described previously [1,16]. In brief, intergenic
and intronic sequences similar (>40% sequence identity) to
human proteins are identified. Putative pseudogenes
covering >70% of their parent proteins without an insertion
longer than 60 nucleotides are then labeled as processed
pseudogenes, and those with a gap as duplicated.
Pseudogenic sequences aligned to only part (<70%) of
proteins are classified as pseudogene fragments.
Routine D focuses on duplicated pseudogenes
A duplicated pseudogene usually contains pseudo-introns.
To exploit this, we revised routine P and developed a new
computational scheme, routine D (for ‘duplicated’), which is
more suitable for identifying duplicated pseudogenes
(Figure 1). As described in detail below , there are two major
changes from routine P: one during the homology search
and the other in assembling search results into putative
pseudogenes. In the homology search step, we used
individual exons (of a gene) as our queries instead of the full
length protein. When assembling pseudo-exons into
pseudogene candidates, we referred to the intron-exon
structures of our query genes to distinguish duplicated from
processed pseudogenes.
Exon based BLAST
For each exon, we retrieved its DNA sequence and an extra
50 nucleotides adjacent to both ends of its exon (Figure 1).
The extra 100 nucleotides are important for separating
duplicated from processed pseudogenes because they enable
our queries to span the pseudo-intron-exon boundaries of
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in-frame translated to peptides and then used by the
program TBLASTN [20] to search for similar sequences in
the ENCODE regions.
Assemble BLAST hits
BLAST hits (that is, the sequence regions found by
TBLASTN) were assembled into pseudogene candidates
based on the intron-exon organization of their query genes.
A hit (putative pseudo-exon) was skipped if it covered less
than half of its query exon, or if it was nearly identical (>95%
sequence identity) to its query. Based on their genomic
coordinates, two neighboring hits were joined together and
labeled as ‘Dup’ if: they were similar to adjacent exons of the
same genes; and the distance between them was within the
size (plus an extra 500 nucleotides) of the intron separating
the two parent exons. They were otherwise labeled as
‘NonDup’ if they were separated by less than 50 nucleotides.
This step noticeably considered the alignment running
across the intron-exon boundary because the distance of two
‘pseudo-exons’ in a processed pseudogene would presu-
mably be 0 or at least less than 50 nucleotides. This labeling
step ran through all BLAST hits. In the end, neighboring hits
were assembled into pseudogene candidates.
Identify the parent gene for a pseudogene
As expected, many pseudogenic regions shared sequence
similarity to more than one gene. For such cases, we enforced
a one-to-one relationship by picking the gene most similar
(defined by the smallest e-value) to this region as its parent.
Align a pseudogene candidate to its parent protein
After the relationship between a pseudogene candidate and its
parent was established, the pseudogenic DNA sequence and
the gene’s ‘protein’ sequence were retrieved from databases
and then aligned using the program GeneWise [28]. We chose
GeneWise because it allows frameshift mutations and can
accommodate very large insertions. GeneMapper [31] will be
an alternative to explore in the future. Furthermore, we also
used information from the alignment to adjust the start and
end positions of a pseudogene. From the final alignments, we
defined the locations of pseudo-exons and pseudo-introns in
reference to the parent proteins. Disablements in the aligned
regions were also used as criteria for our pseudogene
assignment. Finally, we compared a duplicated pseudogene to
its parent gene’s DNA sequence in order to validate our
pseudogene classification and to refine the genomic locations
of a duplicated pseudogene.
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